CATALOGO DEI PRODOTTI DELLA RICERCA

BRONTE, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.247
EU - Europa 10.618
AS - Asia 7.519
SA - Sud America 1.039
AF - Africa 262
Continente sconosciuto - Info sul continente non disponibili 261
OC - Oceania 32
Totale 31.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.028
RU - Federazione Russa 3.457
SG - Singapore 3.181
GB - Regno Unito 2.921
CN - Cina 1.949
IT - Italia 1.197
HK - Hong Kong 825
BR - Brasile 817
DE - Germania 635
VN - Vietnam 547
FR - Francia 545
FI - Finlandia 541
IE - Irlanda 449
SE - Svezia 355
KR - Corea 268
BD - Bangladesh 206
UA - Ucraina 152
IN - India 118
CA - Canada 109
NG - Nigeria 105
NL - Olanda 98
AR - Argentina 80
TR - Turchia 80
JP - Giappone 70
ID - Indonesia 66
ES - Italia 50
MX - Messico 49
ZA - Sudafrica 49
AT - Austria 41
PL - Polonia 33
EC - Ecuador 32
IQ - Iraq 32
CO - Colombia 31
BE - Belgio 30
AU - Australia 23
KE - Kenya 22
PK - Pakistan 21
MA - Marocco 19
PH - Filippine 18
VE - Venezuela 18
PY - Paraguay 16
SA - Arabia Saudita 16
CZ - Repubblica Ceca 14
TN - Tunisia 14
EG - Egitto 13
PE - Perù 13
CL - Cile 12
CR - Costa Rica 12
JM - Giamaica 12
MY - Malesia 12
UZ - Uzbekistan 12
AZ - Azerbaigian 9
BO - Bolivia 9
TG - Togo 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
BJ - Benin 8
IL - Israele 8
NZ - Nuova Zelanda 8
OM - Oman 8
UY - Uruguay 8
DZ - Algeria 7
LT - Lituania 7
RO - Romania 7
TW - Taiwan 7
CH - Svizzera 6
DK - Danimarca 6
GT - Guatemala 6
HU - Ungheria 6
JO - Giordania 6
LB - Libano 6
NI - Nicaragua 6
SI - Slovenia 6
BY - Bielorussia 5
HN - Honduras 5
IR - Iran 5
LV - Lettonia 5
NP - Nepal 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AM - Armenia 4
AO - Angola 4
EE - Estonia 4
LA - Repubblica Popolare Democratica del Laos 4
MK - Macedonia 4
NO - Norvegia 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
ET - Etiopia 3
GR - Grecia 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AD - Andorra 2
BB - Barbados 2
Totale 31.671
Salva come PNG Salva come JPEG
Città #
Southend 2.673
Singapore 1.659
Ashburn 1.498
Jacksonville 1.245
San Jose 1.129
Moscow 1.051
Chandler 857
Woodbridge 851
Hong Kong 805
Dallas 732
Ann Arbor 635
Verona 617
Council Bluffs 529
Houston 448
Dublin 437
The Dalles 409
Beijing 313
Princeton 221
Lawrence 220
Los Angeles 219
Wilmington 218
New York 205
Munich 171
Ho Chi Minh City 168
Helsinki 143
Nanjing 132
Buffalo 122
Shenyang 119
Jinan 118
Hanoi 105
Abuja 102
Milan 94
Sindelfingen 84
Columbus 82
Santa Clara 80
Tianjin 78
Redmond 75
São Paulo 72
Redondo Beach 67
Hebei 66
Tokyo 60
Nanchang 55
San Francisco 53
Orem 52
Haikou 51
Hangzhou 49
Ningbo 49
Zhengzhou 48
Changsha 44
Jakarta 43
Guangzhou 42
Chicago 41
London 41
Toronto 41
Seattle 39
Amsterdam 36
Brooklyn 35
Jiaxing 35
Taizhou 34
Frankfurt am Main 33
Phoenix 33
Turku 32
Norwalk 31
Seoul 31
Brussels 29
Chennai 29
Johannesburg 28
Montreal 28
Nuremberg 28
Stockholm 28
Dong Ket 27
Atlanta 25
Boardman 25
Boston 25
Haiphong 25
Taiyuan 25
Washington 25
Warsaw 24
Denver 22
Redwood City 22
Rio de Janeiro 22
Rome 22
Da Nang 21
Vienna 21
Brasília 20
Dearborn 20
Dongguan 20
Fuzhou 20
Belo Horizonte 19
Falls Church 19
Nairobi 19
Mexico City 18
Madrid 17
Manchester 17
New Delhi 17
Lappeenranta 16
Bologna 15
Grafing 15
Paris 15
Quito 14
Totale 20.639
Salva come PNG Salva come JPEG
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 314
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 305
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 296
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 288
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 269
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 260
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 259
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 256
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 256
Myeloid-derived suppressor cell heterogeneity in human cancers 255
Deciphering the state of immune silence in fatal COVID-19 patients 242
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. 241
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 230
Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. 221
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 220
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 220
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 218
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 217
Antigen specificity of immune suppression by myeloid-derived suppressor cells. 214
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 214
Altered macrophage differentiation and immune dysfunction in tumor development. 211
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 210
Antitumor vaccination: where we stand. 205
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 203
4PD Functionalized Dendrimers: A Flexible Tool for In Vivo Gene Silencing of Tumor-Educated Myeloid Cells 203
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 202
Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins 201
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). 197
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 197
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 196
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. 195
Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. 194
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression 192
Human Anti Cancer Cytokine Induced Killer Cells and TheirInteraction With the Host Immune System 191
Adoptive transfer of lymphokine-activated killer cells loaded with 4'-deoxy-4'-iododoxorubicin: therapeutic effect in mice bearing lung metastases. 190
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases. 188
Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen. 186
Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts. 185
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 183
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 182
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. 181
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 179
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 177
Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. 175
Platelets promote thromboinflammation in SARS-CoV-2 pneumonia 174
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 174
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 171
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+Monocytic Antigen-Presenting Cells in Tumors 171
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. 171
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 171
The Endless Saga of Monocyte Diversity 167
Local ablation disrupts immune evasion in pancreatic cancer 164
Adipocytes and Neutrophils Give a Helping Hand to Pancreatic Cancers 164
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 164
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. 162
Detection and functional evaluation of arginase-1 isolated from human PMNs and murine MDSC 162
The cross-talk between myeloid and mesenchymal stem cells of human bone marrow represents a biomarker of aging that regulates immune response and bone reabsorption 162
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 160
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 159
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. 159
Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area. 157
Transcription factors in myeloid-derived suppressor cell recruitment and function. 156
Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model. 151
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. 149
Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. 148
New idrosoluble furoxan derivatives having antitumoral activity 148
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. 147
PDE5 INHIBITOR COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY 146
Nitric oxide furoxan derivative compounds endowed with antitumoral activity 146
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment 144
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines. 143
Use of myeloid cell biomarkers for the diagnosis of cancer. 142
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 140
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome 140
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. 139
Therapeutic targeting of myeloid-derived suppressor cells. 139
Role of arginine metabolism in immunity and immunopathology. 139
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. 139
Nitric oxide affects immune cells bioenergetics: long-term effects of nitric-oxide derivatives on leukaemic Jurkat cell metabolism 139
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells 138
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 137
Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. 136
IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. 136
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy 136
Derangement of immune responses by myeloid suppressor cells. 134
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. 134
La risposta immunologica verso antigeni tumorali specifici 134
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 133
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. 133
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. 133
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 132
Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity. 132
Meccanismi molecolari della lisi mediata dai linfociti citotossici 132
Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. 131
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. 130
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. 130
Myeloid-derived suppressor cells generated in vitro 130
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 130
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 129
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. 128
Totale 17.813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.205
article - articoli 99.836
book - libri 0
conference - conferenze 2.059
curatela - curatele 0
other - altro 1.715
patent - brevetti 2.003
selected - selezionate 0
volume - volumi 5.592
Totale 222.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.629 0 442 31 52 74 47 70 111 115 89 151 447
2022/20232.728 257 262 303 445 230 632 42 154 294 14 57 38
2023/20241.516 63 98 101 192 209 236 66 140 16 87 239 69
2024/20254.793 275 271 146 710 273 163 330 306 828 281 354 856
2025/202612.684 995 635 782 1.783 2.807 870 1.470 682 1.065 744 329 522
2026/2027533 193 340 0 0 0 0 0 0 0 0 0 0
Totale 31.978